JAMES S. SHANNON, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

MANNKIND CORP

Filing Date Source Excerpt
2017-11-17 James S. Shannon, M.D.(12) 27,674 * Includes 2,472 options and 567 restricted stock units which Dr. Shannon has the right to acquire within 60 days of October 30, 2017 pursuant to the exercise of outstanding options and vesting of restricted stock units.

Data sourced from SEC filings. Last updated: 2025-10-11